Subscribe
istock-669281432_nataliaderiabina
NataliaDeriabina / iStockphoto.com
26 January 2018Americas

Illumina handed $27m in prenatal patent win

A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
Predicting the unpredictable during pregnancy
19 April 2022   A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.
Americas
Federal Circuit denies Illumina’s writ request in Ariosa dispute
10 March 2017   The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics.
Europe
Illumina files patent claim against Ariosa and The Doctors Laboratory
8 January 2016   US-based gene sequencing company Illumina has claimed that The Doctors Laboratory’s use of the Harmony prenatal test provided by Ariosa Diagnostics infringes its patent.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Americas
Federal Circuit denies Illumina’s writ request in Ariosa dispute
10 March 2017   The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics.
Europe
Illumina files patent claim against Ariosa and The Doctors Laboratory
8 January 2016   US-based gene sequencing company Illumina has claimed that The Doctors Laboratory’s use of the Harmony prenatal test provided by Ariosa Diagnostics infringes its patent.
Medtech
Predicting the unpredictable during pregnancy
19 April 2022   A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

More on this story

Americas
Federal Circuit denies Illumina’s writ request in Ariosa dispute
10 March 2017   The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics.
Europe
Illumina files patent claim against Ariosa and The Doctors Laboratory
8 January 2016   US-based gene sequencing company Illumina has claimed that The Doctors Laboratory’s use of the Harmony prenatal test provided by Ariosa Diagnostics infringes its patent.
Medtech
Predicting the unpredictable during pregnancy
19 April 2022   A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility